Teva Offloads Women's Health Business To Two Firms For $1.38Bn
Executive Summary
The generic drug maker signed two deals to divest its women's health business, one with the equity investment firm CVC Capital Partners and the other with Foundation Consumer Healthcare.
You may also be interested in...
Germany First As Pfenex And Alvogen Biosimilar Forsteo Is Launched
After launching in the US last year, the teriparatide product developed by Pfenex and Alvogen has been introduced in Europa, via commercialization partner Theramex, beginning with Germany.
Sanofi's Generics Business To Be Sold To Private Equity Firm, Advent
Sanofi will have €1.9bn to add to its war-chest when it concludes the sale of its European generics business.
Sanofi's Generics Business To Be Sold To Private Equity Firm, Advent
Sanofi will have €1.9bn to add to its war-chest when it concludes the sale of its European generics business.